市场调查报告书
商品编码
1309866
2018-2028年ELISA分析仪市场 - 全球行业规模、份额、趋势、竞争、机会及预测F 按类型、按模式、按应用、按最终用户、按地区和竞争情况进行细分ELISA Analyzers Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Mode, By Application, By End user, By Region and Competition |
预计在 2024-2028 年的预测期内,ELISA 分析仪市场将以惊人的复合年增长率增长。这主要归因于对诊断传染病流行的高效测试需求不断增长,以及对技术先进的疾病检测仪器的需求不断增长等因素。
疾病在人群中的流行率不断上升,推动了 ELISA 分析仪的市场需求。传染病发病率在全球范围内不断上升,引起了全世界人民对健康的极大关注。例如,根据世界卫生组织的数据,2019 年有 2.96 亿人感染乙型肝炎,每年新增感染者约 150 万人。同样,根据世卫组织的报告,登革热病的全球负担有所增加,观察到约 310 万例病例,其中超过 2.5 万例被认为是严重病例。随着癌症、肝炎、艾滋病等传染病发病率的快速增长,对诊断的直接需求也随之激增,从而在预测期内推动了市场的增长。例如,印度制药公司 Biocon 在 2020 年增加了投资,花费了 5879 万美元。
准确、快速地分析生化和免疫参数的维护是分析免疫测试结果的重要要求。分析仪的设计旨在确保检测的理想性能,如保持灵敏度、降低背景噪音和快速重现性。此外,ELISA 分析仪(如开放式系统自动分析仪)配有预编程测试菜单和简单指南,有助于节省安装时间,同时为用户提供方便。例如,2022 年 5 月,高性能生命科学解决方案的领先供应商 Molecular Devices, LLC.该公司为酶联免疫吸附试验(ELISA)工作流程推出了五种现成的新型工作单元,可提供自动化品质,如增加走行时间和吞吐量,减少大量样品中的劳动密集型重复工作,因此预计未来几年市场增长将激增。
酶活性的测量以及可溶性蛋白、细胞因子和其他蛋白体的检测,都促进了 ELISA 分析仪的市场需求。此外,越来越多的过敏病例也导致了对 ELISA 等诊断技术的需求。ELISA 是一种广泛用于检测食物过敏的诊断技术。此外,由于间接 IgE-ELISA 方法与其他自动化系统相比简单、成本低,因此经常用于检测血清样本中的过敏原特异性 IgE。例如,2018 年 7 月,Dynex Technologies 宣布与 ZEUS Scientific 建立全球合作伙伴关系。2021 年 8 月,Zeus Scientific Inc 获得 FDA 授权,可使用 Dynex Agility、Dynex DSX 或 Dynex DS2 自动 ELISA 系统运行 ZEUS ELISA SARS-SoV-2 总抗体检测系统。随着 COVID-19 期间 ELISA 检测试剂盒销售量的增加和需求的上升,ELISA 分析仪的市场需求激增,预计在预测期内将促进 ELISA 分析仪市场的发展。
ELISA 可用于量化抗体滴度,而抗体滴度可进一步用于疫苗开发过程中的免疫原性评估。因此,一些致力于疫苗开发的公司对 ELISA 分析仪的需求不断增加。例如,根据 2022 年 7 月举行的 2022 年第二季度业绩会议的最新消息,领先的制药公司赛诺菲公司有 10 种候选疫苗正在研发中。
TechSci Research 可根据给定的市场数据,按照公司的具体需求提供定制服务。报告可提供以下定制选项:
ELISA Analyzers Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as increasing demand for efficient tests for diagnosing the prevalence of infectious diseases and the growing need for technologically advanced instruments for disease detection, etc.
Enzyme-Linked Immunosorbent Assay (ELISA) is a laboratory test that is utilized for the detection of antibodies in the blood. The ELISA is based on the principle of antibody and antigen interaction and, thereby, is utilized in disease diagnosis. Analyzers are automated instruments that perform distinct steps of the assays and provide accurate and reproducible outcomes.
Moreover, the growing incidences of HIV, hepatitis, cancer, etc., and the rising involvement of ELISA analyzers in research and development involved in immunology and drug development are propelling the market demand for ELISA analyzers and thus supporting the market growth and are expected to propel it in the forecast period.
The growing prevalence of a disease among the population is propelling the market demand for ELISA analyzers. Rising infectious disease prevalence is growing worldwide, causing a huge health concern among people around the world. With this rapid increase in the account for infectious diseases such as cancer, hepatitis, HIV, etc., there is a surge observed in the direct demand for diagnosis and, thus, is adding to the market growth by propelling the market in the forecast period. For instance, Indian-based pharmaceutical company Biocon increased investment and spent USD 58.79 million in the year 2020.
The accuracy and quick analysis of the biochemical and immunological parameters maintenance is a significant requirement for the analysis of immunological test results. Analyzers are designed in such a way as to ensure the ideal performance of the assays, such as maintaining sensitivity, lesser background noise, and quick reproducibility. Also, the ELISA analyzers, such as open system automated analyzers, are fitted with pre-programmed test menus and simple guides that aid in saving installation along with providing the user convenience. For instance, In May 2022, Molecular Devices, LLC., a leading provider of high-performance life science solutions, launched its automated work cells for ELISA workflows. The company introduced its five readymade new work cells for Enzyme-linked immunosorbent assay (ELISA) workflows, which provide automation qualities such as increased walkaway time and throughput, reducing the labor-intensive, repetitive work in large samples, and thereby is expected to surge the market growth in the coming years.
The measurement of enzyme activity, along with the detection of soluble proteins, cytokines, and other protein bodies, is fueling the ELISA analyzers' market demand. Additionally, the growing case of allergies has led to demand for diagnostic techniques such as ELISA. ELISA is a widely used diagnostic technique in the detection of food allergies. Furthermore, the indirect IgE-ELISA method is frequently used to detect allergen-specific IgE in serum samples due to its simplicity and low cost compared with other automated systems. For instance, In July 2018, Dynex Technologies announced its global Partnership with ZEUS Scientific. In August 2021, Zeus Scientific Inc obtained FDA authorization to use the Dynex Agility, Dynex DSX, or Dynex DS2 Automated ELISA Systems to run the ZEUS ELISA SARS-SoV-2 total antibody test system. The surge in market demand for ELISA analyzers is experienced with the increased sales and rising demand for ELISA test kits during the COVID-19 duration and is anticipated to bolster the ELISA analyzer market in the forecast period.
ELISA is utilized to quantify antibody titers which are further utilized for the assessment of immunogenicity during vaccine development. Hence, several companies leading to their vaccine development have an increased demand for ELISA analyzers. For instance, a leading pharmaceutical company, Sanofi Incorporation, has 10 vaccine candidates in its pipeline, according to the latest updates at the Q2 2022 results meeting, which was held in July 2022.
ELISA Analyzers Market is segmented based on the type, mode, application, end-user, and region. Based on the type, the market is further segmented into optical filter ELISA analyzers and optical grating ELISA analyzers. Based on the mode, the market is segmented into automated ELISA analyzers and semi-automated analyzers. Based on application, the market is further fragmented into immunology, vaccine development, drug monitoring, and others. Depending on the End-user, the market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations, and diagnostic laboratories. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, Danaher Corporation, BioTech, Agilent Technologies, QIAGEN, and PerkinElmer Inc.., etc.., are some of the major players operating in the Global ELISA Analyzers Market.
In this report, Global ELISA Analyzers Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in ELISA Analyzers Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: